Skip to content

EFFECT OF ASHWAGANDHA BASED TAKRADHARA THERAPY ON STRESS HORMONE LEVELS IN INSOMNIA.

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF ASHWAGANDHA SADHITA TAKRADHARA ON SERUM CORTISOL LEVLES IN NIDRANASHA WITH SPECIAL REFERENCE TO INSOMNIA. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106235
Enrollment
30
Registered
2026-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition

Interventions

None listed

Sponsors

SDM College Of Ayurveda, Hospital and Research Centre, Udupi.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects fulfilling the DSM-5-TR and ICD-10 Diagnostic criteria for Insomnia. 2.Age group between 18-60 years. 3.Subjects indicated for Takradhara.

Exclusion criteria

Exclusion criteria: 1.Patients diagnosed with other Primary sleep-awake disorders. 2.Patients with severe psychiatric comorbidities such as major depressive disorder with suicidal ideation, bipolar disorder(manic phase), Psychosis or severe anxiety disorders requiring intensive psychiatric intervention. 3.Patients currently on medications known to significantly affects sleep (e.g. hypnotics, sedatives, certain antidepressants with sedative effects. 4.Patients on corticosteroids or other hormonal therapies that significantly influence cortisol levels. 5.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Significant improvement in the sleep quality post Ashwagandha sadhita takradhara assessed through subjective and objective parameters.Timepoint: Before treatment 0th day, after treatment 8th day and follow up on 15th day

Secondary

MeasureTime frame
1.Generation of data on quality of life improvement post treatment assessed based on QOL-I Scale. 2.Generation of data on probable, potential adverse drug events related to study, if any.Timepoint: Before treatment 0th day, after treatment 8th day and follow up on 15th day

Countries

India

Contacts

Public ContactDr RAJALAXMI MG

SDM College of Ayurveda, Hospital and Research Centre, Udupi.

drrajalaxmisdm@gmail.com9448951673

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026